4月8日,FDA 向 Fontem U.S. LLC 发布了myblu 产品的营销拒绝令 (MDO),这些产品包括:
- myblu Device Kit
- myblu Intense Tobacco Chill 2.5%
- myblu Intense Tobacco Chill 4.0%
- myblu Intense Tobacco 2.4%
- myblu Intense Tobacco 3.6%
- myblu Gold Leaf 1.2%
- myblu Gold Leaf 2.4%
Fontem US是Imperial Brands(帝国烟草)的电子烟产品部门,Myblu是Fontem US旗下电子烟品牌Blu的一个系列。有资料显示,Blu在国内的主要代工厂是惠州市天长实业有限公司。
这是第一家大型国际烟草公司的电子烟产品PMTA申请被FDA拒绝。
海外媒体报道称,Blu的其他产品仍在审查中,比如Blu的一次性电子烟和可充电的Blu Plus+。Myblu的两款薄荷醇口味烟弹还在审查中,但烟杆没通过,烟弹通过估计也没有意义。
“Other Blu products, including Blu’s disposable cigalikes and rechargeable PLUS+ cigalikes, are still under review by the FDA. Oddly, two menthol myblu pods also remain under review, although they would be entirely useless without the already-denied device required to vape them.”By Vaping360
相关阅读:
原文始发于微信公众号(艾邦新消费电子资讯):帝国烟草旗下电子烟Myblu被FDA拒绝上市销售
电子雾化与HNB产品都是新型电子产品,结构虽小,却融合应用多种材料、表面处理、芯片电子等技术工艺,而且雾化技术一直在不断更迭,供应链在逐步完善,为了促进供应链企业间有一个良好的对接交流,艾邦搭建产业微信群交流平台,欢迎加入;Vape e-cigarettes (VAPE) and Heat-Not-Burn e-cigarettes (HNB) are both emerging electronic products. Despite their compact size, they integrate various materials, surface treatment technologies, chip electronics, and other advanced technical processes. Moreover, atomization technology is constantly evolving and the supply chain is being progressively perfected. To facilitate good communication and networking among supply chain enterprises, Aibang has established an industry WeChat group communication platform and warmly welcomes interested enterprises to join.